Activin and Inhibin

Febantel.

Febantel.

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Product Description：Febuxostat(TEI 6720:TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase.Febuxostat is a potent, non-purine compound, which inhibits the expression of

Fedovapagon (VA106483) is a selective and orally active Vasotocin V2 receptor (V2R) agonist with an EC 50 of 24 nM. Fedovapagon can be used in the research of nocturiaIn VivoFedovapagon (1 mg/kg, oral administration) inhibits urine output with 81%

Fedovapagon (VA106483) is a selective and orally active Vasotocin V2 receptor (V2R) agonist with an EC 50 of 24 nM. Fedovapagon can be used in the research of nocturiaIn VivoFedovapagon (1 mg/kg, oral administration) inhibits urine output with 81%

Fedovapagon (VA106483) is a selective and orally active Vasotocin V2 receptor (V2R) agonist with an EC 50 of 24 nM. Fedovapagon can be used in the research of nocturiaIn VivoFedovapagon (1 mg/kg, oral administration) inhibits urine output with 81%